Filter
538
Filtered Results: 538
Text search:
Brand,
P.L.
et
al.
Featured
Recommendations
55
New Publications
98
Language
Document type
No document type
247
Studies & Reports
138
Guidelines
83
Manuals
37
Strategic & Response Plan
15
Training Material
8
Fact sheets
8
Situation Updates
1
Resource Platforms
1
Countries / Regions
India
26
Global
19
Brazil
14
Western and Central Europe
12
Russia
11
Germany
10
South Africa
10
Eastern Europe
8
Kenya
7
Africa
7
Bangladesh
7
Sierra Leone
6
Uganda
6
Ethiopia
6
Nepal
5
Ukraine
5
Nigeria
5
South–East Asia Region
5
Liberia
5
Mozambique
4
Latin America and the Carribbean
4
Thailand
3
Syria
3
Philippines
3
Guinea
3
Cambodia
3
Asia
3
Tanzania
3
Middle East and North Africa
3
East and Southern Africa
3
Argentina
3
Indonesia
3
China
2
Rwanda
2
Burkina Faso
2
Zimbabwe
2
Congo, Democratic Republic of
2
West and Central Africa
2
United Kingdom
2
Sri Lanka
2
Namibia
2
Yemen
2
Angola
2
Botswana
2
Zambia
2
South Sudan
2
Colombia
1
Lesotho
1
Ghana
1
Benin
1
Kazakhstan
1
Chile
1
Cameroon
1
Canada
1
Singapore
1
Senegal
1
Afghanistan
1
Malawi
1
USA
1
Haiti
1
Guinea-Bissau
1
Western Pacific Region
1
Paraguay
1
North America
1
Portugal
1
Spain
1
Israel
1
Latvia
1
Southern Africa
1
Vietnam
1
Palestine
1
Somalia
1
Myanmar / Burma
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
147
Clinical Guidelines
57
Public Health
36
Women & Child Health
24
Key Resources
17
Pharmacy & Technologies
13
Capacity Building
4
Toolboxes
Mental Health
68
COVID-19
47
HIV
46
NTDs
34
TB
32
Planetary Health
29
AMR
21
Pharmacy
18
NCDs
18
Rapid Response
15
Disability
15
Refugee
11
Ebola & Marburg
11
Caregiver
7
Global Health Education
7
Zika
5
Natural Hazards
4
Social Ethics
4
Health Financing Toolbox
4
Specific Hazards
3
Conflict
2
Polio
2
Cholera
1
The Faster We Go, the Health We'll Be.
The report outlines five climate solutions that research shows will deliver immediate, often localized, health and equity benefits. Our focus is on the solutions that proactively advance both health and health equity, recognizing that some of us face greater h...
Terminology used to describe the transmission of pathogens through the air varies across scientific disciplines, organizations and the general public. While this has been the case for decades, during the coronavirus disease (COVID-19) pandemic, the terms ‘airborne’, ‘airborne transmission’ a...
Human African trypanosomiasis (HAT) has been an alarming global public health issue. The disease affects mainly poor and marginalized people in low-resource settings and is caused by two subspecies of haemoflagellate parasite, Trypanosoma brucei and transmitted by tsetse flies. Progress made in HAT ...
Health, Rights and Drugs
recommended
Harm Reducation, Decriminalization and Zero Discrimination for People who use Drugs
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...
Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these countries, IHD mortality rates are significantly greater in individuals of a low socioeconomic status (...
We are IntechOpen, the world’s leading publisher of Open Access books Built by scientists, for scientists
Selection of our books indexed in the Book Citation Index in Web of ScienceTM Core Collection (BKCI)
http://dx.doi.org/10.5772/intechopen.68759
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi...
Ramped-up cancer services could save 7 million lives over the next decade—and addressing huge service gaps between rich and poor countries is key to success, according to this report.
In 2019, over 90% of high-income countries reported that comprehensive cancer treatment services were available...
Joint United Nations Programme on HIV/AIDS
Why bold action against inequalities is needed to en AIDS, stop COVID-19 and prepare for future pandemics
This interim guidance is for LTCF managers and corresponding infection prevention and control (IPC) focal persons in LTCF and updates the guidance published in March 2020. The objective of this document is to provide guidance on IPC in LTCFs in the context of COVID-19 to 1) prevent COVID-19-virus fr...
MAMI refers to the management of small and nutritionally at risk infants under six months of age (infants u6m) and their mothers.
This course describes the health effects of war, weapons and strategies of violent conflict. Beginning with weapons of mass destruction it then moves on to other weapons and strategies of war such as the use of landmines and mass rape. The course concludes with a number of lessons which give an hist...
This Rapid Advice Guideline updates the Interim Guidance on the “Assessment of infants with microcephaly in the context of Zika virus” published in February 2016 (WHO/ZIKV/MOC/16.3). The recommendations provides guidance on the screening, clinical assessment, neuroimaging, laboratory investigati...
Responses to epidemics, emergencies and disasters raise many ethical issues for the people involved, including public health specialists and policy makers. This training manual provides material on ethical issues in research, surveillance and patient care in these difficult contexts.
A toolkit for pharmacists.
Emerging data show that medication errors and adverse events cause significant harm to patients’ health and
well-being. It is estimated that the burden of adverse events due to medicines is now comparable to that of
widespread diseases, such as malaria or tuberculosis...
